News | March 13, 2022
Japan tops CPhI ‘API Quality’ ranking for second year
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Tislelizumab is now approved for seven indications in China
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
The product will be manufactured at Lupin’s facility in Goa, India
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Subscribe To Our Newsletter & Stay Updated
